5285
Sime Darby Plantation Berhad
Sector: Plantation | Market: MAIN
Key Financials
Extracted from official Bursa Malaysia quarterly filings. Latest 4 quarters, side by side.
Q4 FY2025Q3 FY2025Q2 FY2025Q1 FY2025
Income Statement
| Metric | Q4 FY2025 RM '000 | Q3 FY2025 RM '000 | Q2 FY2025 RM '000 | Q1 FY2025 RM '000 |
|---|---|---|---|---|
| Revenue (Quarter ended 30 June 2025) | - | - | 5,169 | - |
| Revenue | 20,895 | 5,411 | - | 4,817 |
| Revenue (Half year-ended 30 June 2025) | - | - | 9,986 | - |
| Operating expenses | -18,056 | -4,682 | - | -4,078 |
| Cost of sales | - | -4,682 | - | - |
| Other operating income | 737 | - | - | 97 |
| Operating expenses (Quarter ended 30 June 2025) | - | - | -4,434 | - |
| Gross profit | - | 0 | - | - |
| Operating expenses (Half year-ended 30 June 2025) | - | - | -8,512 | - |
| Other gains/(losses) | 26 | - | - | - |
| Other losses | - | - | - | -10 |
| Operating profit | 3,602 | - | - | 826 |
| Finance costs | -87 | -19 | - | -25 |
| Other operating income (Quarter ended 30 June 2025) | - | - | 41 | - |
| Share of results of joint ventures | -13 | - | - | -7 |
| Profit before tax | 3,530 | 1,251 | - | 799 |
| Other operating income (Half year-ended 30 June 2025) | - | - | 138 | - |
| Other gains/(losses) (Quarter ended 30 June 2025) | - | - | 26 | - |
| Tax expense | -842 | -271 | - | -183 |
| Share of results of associates | 4 | - | - | -1 |
| Other gains/(losses) (Half year-ended 30 June 2025) | - | - | 16 | - |
| Profit before interest and tax | 3,593 | - | - | 818 |
| Net profit | - | 980 | - | 567 |
| Operating profit (Quarter ended 30 June 2025) | - | - | 802 | - |
| Finance income | 24 | - | - | 6 |
| Earnings per share - Basic (sen) | - | 0.014 | - | - |
| Operating profit (Half year-ended 30 June 2025) | - | - | 1,628 | - |
| Share of results of joint ventures (Quarter ended 30 June 2025) | - | - | -3 | - |
| Share of results of joint ventures (Half year-ended 30 June 2025) | - | - | -10 | - |
| Profit for the financial year | 2,688 | - | - | - |
| Share of results of associates (Quarter ended 30 June 2025) | - | - | 5 | - |
| Profit for the financial period | - | - | - | 616 |
| Share of results of associates (Half year-ended 30 June 2025) | - | - | 4 | - |
| Profit after tax attributable to equity holders of the Company | 2,503 | - | - | - |
| Profit attributable to equity holders of the Company | - | - | - | 567 |
| Profit before interest and tax (Quarter ended 30 June 2025) | - | - | 804 | - |
| Basic earnings per share (sen) | 0.036 | - | - | - |
| EPS - Basic (sen) | - | - | - | 0.008 |
| Profit before interest and tax (Half year-ended 30 June 2025) | - | - | 1,622 | - |
| Finance income (Quarter ended 30 June 2025) | - | - | 5 | - |
| Finance income (Half year-ended 30 June 2025) | - | - | 11 | - |
| Finance costs (Quarter ended 30 June 2025) | - | - | -26 | - |
| Finance costs (Half year-ended 30 June 2025) | - | - | -51 | - |
| Profit before tax (Quarter ended 30 June 2025) | - | - | 783 | - |
| Profit before tax (Half year-ended 30 June 2025) | - | - | 1,582 | - |
| Tax expense (Quarter ended 30 June 2025) | - | - | -234 | - |
| Tax expense (Half year-ended 30 June 2025) | - | - | -417 | - |
| Profit for the financial period (Quarter ended 30 June 2025) | - | - | 549 | - |
| Profit for the financial period (Half year-ended 30 June 2025) | - | - | 1,165 | - |
| Profit for the financial period attributable to equity holders (Quarter ended 30 June 2025) | - | - | 505 | - |
| Profit for the financial period attributable to equity holders (Half year-ended 30 June 2025) | - | - | 1,072 | - |
| Earnings per share - Basic (Quarter ended 30 June 2025) | - | - | 0 | - |
| Earnings per share - Basic (Half year-ended 30 June 2025) | - | - | 0 | - |
Balance Sheet
| Metric | Q4 FY2025 RM '000 | Q3 FY2025 RM '000 | Q2 FY2025 RM '000 | Q1 FY2025 RM '000 |
|---|---|---|---|---|
| Non-current assets | 0 | 0 | 0 | 15,843.2 |
| Property, plant and equipment | 19.341 | 19,250 | 19,188 | 19,305 |
| Investment properties | 0.008 | 8 | 8 | 8 |
| Right-of-use assets | 1.85 | 1,865 | 1,894 | 1,942 |
| Joint ventures | 0.582 | 642 | 612 | 637 |
| Associates | 0.052 | 54 | 53 | 51 |
| Intangible assets | 2.732 | 2,818 | 2,834 | 2,983 |
| Investments at fair value through other comprehensive income ("FVOCI") | 0.024 | 32 | 32 | 32 |
| Deferred tax assets | 0.442 | 472 | 421 | 465 |
| Tax recoverable | 0.121 | 79 | 90 | 252 |
| Trade and other receivables (non-current) | - | 52 | 56 | - |
| Total non-current assets | 25.203 | 25,272 | 25,188 | - |
| Current assets | 0 | 0 | 0 | 6,917 |
| Inventories | 2.802 | 3,189 | 3,220 | 3,118 |
| Biological assets | 0.181 | 242 | 217 | 248 |
| Trade and other receivables (current) | - | 2,466 | 2,596 | - |
| Tax recoverable (current) | - | 186 | 260 | - |
| Trade and other receivables | 2.766 | - | - | 2,655 |
| Amounts due from related parties | 0 | 0 | 0 | 0 |
| Non-current assets Total | - | - | - | 25,680 |
| Derivatives (current) | - | 10 | 33 | - |
| Bank balances, deposits and cash | 0.624 | 694 | 557 | 638 |
| Total current assets | 6.519 | 6,787 | 6,883 | - |
| Non-current assets held for sale | 0.021 | 123 | 148 | 148 |
| Total assets | 31.743 | 32,182 | 32,219 | 32,745 |
| Equity | 0 | 0 | 0 | 20,665 |
| Share capital | 1.634 | 1,634 | 1,634 | 1,634 |
| Derivatives | 0.022 | - | - | 23 |
| Reserves | 16.605 | 16,681 | 16,462 | 16,391 |
| Attributable to equity holders of the Company | 18.239 | 18,315 | 18,096 | 18,025 |
| Perpetual Sukuk | 2.231 | 2,200 | 2,231 | 2,200 |
| Current assets Total | - | - | - | 6,917 |
| Non-controlling interests | 0.401 | 427 | 439 | 440 |
| Total equity | 20.871 | 20,942 | 20,766 | 20,665 |
| Non-current liabilities | 0 | 0 | 0 | 6,458 |
| Retirement benefits | 0.017 | 198 | - | 21 |
| Deferred income | 0.038 | 38 | 0 | 0 |
| Deferred tax liabilities | 2.695 | 2,688 | 2,674 | 2,690 |
| Borrowings (non-current) | - | 3,180 | 3,221 | - |
| Lease liabilities (non-current) | - | 187 | 191 | - |
| Trade and other payables (non-current) | - | 53 | 52 | - |
| Total non-current liabilities | 7.679 | 6,344 | 6,334 | - |
| Current liabilities | 0 | 0 | 0 | 5,611 |
| Trade and other payables (current) | - | 2,311 | 2,254 | - |
| Contract liabilities | 0.056 | 58 | 77 | 116 |
| Borrowings | 0.49 | - | - | 1,916 |
| Lease liabilities | 0.033 | - | - | 27 |
| Amounts due to related parties | 0.016 | 10 | 9 | 10 |
| Retirement benefits (current) | - | 19 | 21 | - |
| Trade and other payables | 2.366 | - | - | 2,416 |
| Lease liabilities (current) | - | 23 | 26 | - |
| Non-current liabilities Total | - | - | - | 6,458 |
| Tax payable | 0.193 | 367 | 267 | 272 |
| Derivatives (current) liabilities | - | 10 | 25 | - |
| Borrowings (current) | - | 1,549 | 2,426 | - |
| Dividend payable | - | 536 | - | 810 |
| Liabilities directly associated with non-current assets held for sale (current) | - | 13 | - | - |
| Total current liabilities | 3.193 | 4,883 | 5,105 | - |
| Total liabilities | 10.872 | 11,240 | 11,453 | 12,080 |
| Total equity and liabilities | 31.743 | 32,182 | 32,219 | 32,745 |
| Retirement benefits (non-current) | - | - | 196 | - |
| Liabilities directly associated with non-current assets held for sale | 0 | - | 14 | 11 |
| Current liabilities Total | - | - | - | 5,611 |
Cash Flow Statement
| Metric | Q4 FY2025 RM '000 | Q3 FY2025 RM '000 | Q2 FY2025 RM '000 | Q1 FY2025 RM '000 |
|---|---|---|---|---|
| Cash flows from operating activities | 0 | 0 | 0 | 0 |
| Profit for the financial period | - | 2,145 | 1,165 | 616 |
| Adjustments for: | 0 | 0 | 0 | 0 |
| Share of results of joint ventures and associates | 9 | -36 | 6 | 8 |
| Finance income | -24 | -17 | -11 | -6 |
| Finance costs | 87 | 70 | 51 | 25 |
| Profit for the financial year | 2,688 | - | - | - |
| Gain on disposal of: | - | 0 | - | 0 |
| - property, plant and equipment | 124 | 103 | - | 76 |
| - non-current assets held for sale | 587 | 573 | - | - |
| - a joint venture | 40 | 39 | - | - |
| Depreciation and amortisation | 1,439 | 1,059 | 710 | 356 |
| Net gain on disposal of: | 0 | - | - | - |
| Unrealised fair value losses/(gains): | 0 | 0 | - | 0 |
| - commodities contracts | 15 | 7 | - | 7 |
| - forward foreign exchange contracts | -12 | -13 | - | 1 |
| Unrealised foreign exchange losses/(gains) | 23 | 14 | - | - |
| – an associate | 2 | 2 | - | - |
| Tax expense | 842 | 688 | 417 | 183 |
| Fair value changes on biological assets | 47 | -4 | 26 | 0 |
| – a subsidiary | 98 | - | - | - |
| Retirement benefits | 19 | 39 | 25 | 10 |
| Net of impairment/(reversal) of: | 0 | 0 | - | 0 |
| Unrealised foreign exchange losses | - | - | 15 | 66 |
| - intangible assets | -58 | -23 | - | -20 |
| - right-of-use assets | - | 1 | - | - |
| - goodwill | 9 | 8 | - | - |
| - advances for plasma plantation projects | -3 | -3 | -2 | -1 |
| - trade and other receivables | -436 | -63 | -178 | -222 |
| Gain on disposal of property, plant and equipment | - | - | -82 | - |
| Write off/(Reversal of write off) of: | - | 0 | - | - |
| - inventories | -74 | -397 | -423 | -248 |
| Write off of: | 0 | - | - | 0 |
| – amount due from joint venture | 1 | - | - | - |
| Unrealised fair value losses: commodities contracts | - | - | 6 | - |
| Unrealised fair value losses: forward foreign exchange contracts | - | - | 3 | - |
| Write back of inventories | - | - | - | -24 |
| (Write back)/Write-down of inventories | -15 | -6 | - | - |
| Dividend income from other investments | -5 | -3 | -2 | -2 |
| 1,173 | - | - | - | 1,173 |
| Changes in working capital: | 0 | 0 | 0 | 0 |
| Net of reversal/impairment of property, plant and equipment | - | - | -3 | - |
| Net of reversal/impairment of non-current assets held for sale | - | - | 0 | - |
| Trade and other payables | 10 | -140 | -234 | -56 |
| Net of reversal/impairment of advances for plasma plantation projects | - | - | -1 | - |
| Intercompany and related party balances | - | - | - | -4 |
| Related party balances | 2 | -4 | -5 | - |
| Net of reversal/impairment of trade and other receivables | - | - | -1 | - |
| Cash generated from operations | 4,083 | 2,844 | 1,504 | 643 |
| Write off of inventories | - | - | 1 | - |
| Write off of trade and other receivables | - | - | 0 | - |
| 4,581 | 4,581 | - | - | - |
| Tax paid | -450 | -262 | -141 | -92 |
| Retirement benefits paid | -35 | -25 | -15 | -8 |
| Write off of property, plant and equipment | - | - | 10 | - |
| Net cash generated from operating activities | 3,598 | 2,557 | 1,348 | 543 |
| Write off of intangible assets | - | - | 0 | - |
| Cash flows from investing activities | 0 | 0 | 0 | 0 |
| Write-down/(write back) of inventories | - | - | 9 | - |
| Finance income received | 24 | 17 | 11 | 6 |
| Purchase of: | 0 | 0 | - | 0 |
| Total adjustments subtotal | - | - | 2,344 | - |
| Investment in joint ventures | -275 | -274 | - | - |
| Investment in a joint venture | - | - | -271 | -249 |
| Advances to a joint venture | -90 | -90 | - | - |
| Proceeds from sale of: | 0 | 0 | - | 0 |
| Repayment of advances for plasma plantation projects | 1 | 1 | - | - |
| Dividend received from other investments | - | - | - | 2 |
| Net cash used in investing activities | -1,668 | -1,000 | -1,014 | -566 |
| Cash flows from financing activities | 0 | 0 | 0 | 0 |
| Distribution to Perpetual Sukuk holders | -124 | -124 | -62 | -62 |
| Dividend received from : | 0 | 0 | - | - |
| Finance costs paid | -231 | -178 | -123 | -60 |
| - other investments/FVOCI | 5 | 3 | - | - |
| Loans raised | 6,321 | 3,471 | 2,888 | 1,290 |
| Purchase of property, plant and equipment | - | - | -832 | - |
| Purchase of intangible assets | - | - | -8 | - |
| Loan repayments | -6,416 | -3,787 | -2,294 | -1,148 |
| Borrowing transaction cost paid | -3 | -2 | -2 | -2 |
| Repayment of lease liabilities | -88 | -38 | -23 | -9 |
| Dividends paid to shareholders | -1,346 | -810 | -810 | 0 |
| Proceeds from sale of property, plant and equipment | - | - | 84 | - |
| Dividend received from other investments/FVOCI | - | - | 2 | - |
| Dividends paid to non-controlling interests of subsidiaries | -56 | -33 | -17 | -11 |
| Net cash used in financing activities | -1,943 | -1,501 | -443 | -2 |
| Dividend received from an associate | - | - | 2 | - |
| Net changes in cash and cash equivalents during the financial period | - | 56 | -109 | -25 |
| Foreign exchange difference | 12 | 13 | 41 | 38 |
| Cash and cash equivalents at beginning of the financial period | - | 625 | 625 | 625 |
| Cash and cash equivalents at end of the financial period | - | 694 | 557 | 638 |
| Net changes in cash and cash equivalents during the financial year | -13 | - | - | - |
| Cash and cash equivalents at beginning of the financial year | 625 | - | - | - |
| Cash and cash equivalents at end of the financial year | 624 | - | - | - |
Investor Solutions
What's slowing down your research?
We're building customized tools for investors. Tell us your biggest challenge and we'll let you know when we solve it.